Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
NEW YORK (Reuters Health) – Although the pharmacokinetics (PK) and pharmacodynamics (PD) of high-dose human regular U-500 and human regular U-100 insulin are similar, the U-500 formulation may…
NEW YORK (Reuters Health) – Insulin resistance shows no significant association with an increased risk of atrial fibrillation, researchers report in an October 14th on-line paper in the…
NEW YORK (Reuters Health) – Vandetanib shows encouraging action against advanced and metastatic medullary thyroid carcinoma, researchers report in an October 24th on-line paper in the Journal of…
NEW YORK (Reuters Health) – More intensive blood glucose lowering won’t reduce the risk of heart failure in patients with type 2 diabetes, and when achieved with a…
NEW YORK (Reuters Health) – Polycystic ovary syndrome (PCOS) does not appear to increase the risk of cardiovascular events among postmenopausal women, researchers from Sweden report in the…
NEW YORK (Reuters Health) – Insulin sensitizers may reduce the accelerated loss in muscle mass and strength seen in elderly men with type 2 diabetes, according to a…
NEW YORK (Reuters Health) – Bariatric surgery and its associated weight loss significantly improve the cardiovascular risk profile of obese patients, according to findings published in the August…
NEW YORK (Reuters Health) – Lifestyle changes and treatment with metformin may offset the development of the metabolic syndrome related to androgen deprivation therapy in men with prostate…
NEW YORK (Reuters Health) – Patients with diabetes achieve faster control of A1C, blood pressure and cholesterol targets when they see or have contact with their primary care…
NEW YORK (Reuters Health) – Women with familial hypercholesterolemia (FH) do not appear to be at increased risk of adverse pregnancy outcomes, Norwegian researchers report in a September…
